ABANZA is a company specialized in the biomedical sector dedicated to research and technological development in the field of sports medicine.

Its main objective is the research and development of disruptive innovations in the field of sports medicine, with the aim of bringing them to the market.

ABANZA develops new surgical techniques, implantable devices, and medical instruments with the mission of improving the results obtained with current procedures and devices through innovation. This provides doctors with the necessary tools to ensure faster and more effective rehabilitation for their patients. 

The company began by focusing on achieving anatomically and functionally effective restoration of the Anterior Cruciate Ligament (ACL) of the knee. It has already developed a tibial fixation system for soft connective tissue and is in the process of developing devices for other parts of the body.

The company has a multidisciplinary and highly qualified technical team, combining medical and biomedical engineering knowledge, which guarantees the quality and reliability of the devices developed, offering the best care for the patient.